TOPIRAMATE
- Product NDC
- 72603-120
- 11-digit product format
- 726030120
- Labeler code
- 72603
- Product ID
- 72603-120_f853ce07-7fb8-4c3a-96bc-9f4990f73351
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- topiramate
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- NorthStar RxLLC
- Application
- ANDA210278
- Marketing category
- ANDA
- Marketing start
- 2023-01-01
- Substance
- TOPIRAMATE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A210278-001 | TOPIRAMATE | TOPIRAMATE | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | |
| A210278-002 | TOPIRAMATE | TOPIRAMATE | 50MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | |
| A210278-003 | TOPIRAMATE | TOPIRAMATE | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | |
| A210278-004 | TOPIRAMATE | TOPIRAMATE | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | |
| A210278-005 | TOPIRAMATE | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A210278-001 | AB2 |
| A210278-002 | AB2 |
| A210278-003 | AB2 |
| A210278-004 | AB2 |
| A210278-005 | AB2 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A210278-001 | TOPIRAMATE | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A210278-002 | TOPIRAMATE | 50MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A210278-003 | TOPIRAMATE | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A210278-004 | TOPIRAMATE | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A210278-005 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A210278-001 | TOPIRAMATE | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A210278-002 | TOPIRAMATE | 50MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A210278-003 | TOPIRAMATE | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A210278-004 | TOPIRAMATE | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A210278-005 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A210278-001 | TOPIRAMATE | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A210278-002 | TOPIRAMATE | 50MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A210278-003 | TOPIRAMATE | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A210278-004 | TOPIRAMATE | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A210278-005 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210278-001 | TOPIRAMATE | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210278-002 | TOPIRAMATE | 50MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210278-003 | TOPIRAMATE | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210278-004 | TOPIRAMATE | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210278-005 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A210278-001 | TOPIRAMATE | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A210278-002 | TOPIRAMATE | 50MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A210278-003 | TOPIRAMATE | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A210278-004 | TOPIRAMATE | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A210278-005 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210278-001 | TOPIRAMATE | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210278-002 | TOPIRAMATE | 50MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210278-003 | TOPIRAMATE | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210278-004 | TOPIRAMATE | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210278-005 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210278-001 | TOPIRAMATE | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210278-002 | TOPIRAMATE | 50MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210278-003 | TOPIRAMATE | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210278-004 | TOPIRAMATE | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210278-005 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210278-001 | TOPIRAMATE | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210278-002 | TOPIRAMATE | 50MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210278-003 | TOPIRAMATE | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210278-004 | TOPIRAMATE | 150MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210278-005 | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB2 | 2021-02-01 | 03ed91905a0d… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A210278-001 | AB2 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A210278-002 | AB2 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A210278-003 | AB2 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A210278-004 | AB2 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A210278-005 | AB2 | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A210278-001 | AB2 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A210278-002 | AB2 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A210278-003 | AB2 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A210278-004 | AB2 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A210278-005 | AB2 | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A210278-001 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A210278-002 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A210278-003 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A210278-004 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A210278-005 | AB2 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210278-001 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210278-002 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210278-003 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210278-004 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210278-005 | AB2 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A210278-001 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A210278-002 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A210278-003 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A210278-004 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A210278-005 | AB2 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210278-001 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210278-002 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210278-003 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210278-004 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210278-005 | AB2 | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210278-001 | AB2 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210278-002 | AB2 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210278-003 | AB2 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210278-004 | AB2 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210278-005 | AB2 | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210278-001 | AB2 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210278-002 | AB2 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210278-003 | AB2 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210278-004 | AB2 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210278-005 | AB2 | 1 | 03ed91905a0d… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TOPIRAMATE
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TOPIRAMATE | 25 mg/1 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e5b1b0ba-27f8-4d5d-8943-8aed080fdedc | Product name | 4 | 20260306 |
| 6c26dd6d-01b5-4a80-b096-b3a6f7ca6077 | Product name | 2 | 20250623 |
| cb966f54-bbf0-40fb-b581-80c6648d510c | Product name | 4 | 20250623 |
| 6e2fb0d7-40d7-e97c-1375-fa022ff20193 | Product name | 4 | 20250305 |
| 3d272a3f-17c0-421d-bc43-3cbdb719258d | Product name | 1 | 20250303 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72603-120-01 | TOPIRAMATE | 30 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 30 | 5 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72603-120-01 | EA - Each | 72603-120 | de8276fb-549f-4227-abb3-b45de8c21123 | 1 | 2023-02-06 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TOPIRAMATE | TOPIRAMATE | Glenmark Pharmaceuticals Inc., USA | 54bfabce-1f8a-40ee-8b55-efce8fe6fbf1 | 2026-04-30 | Warnings, Adverse reactions | 210278 ANDA210278 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1812427 | topiramate 100 MG Sprinkle 24HR Extended Release Oral Capsule | PSN | b5f8da43-6daf-413c-9dcd-363617973738 | 5 |
| 1494769 | topiramate 150 MG Sprinkle 24HR Extended Release Oral Capsule | PSN | b5f8da43-6daf-413c-9dcd-363617973738 | 5 |
| 1812419 | topiramate 200 MG Sprinkle 24HR Extended Release Oral Capsule | PSN | b5f8da43-6daf-413c-9dcd-363617973738 | 5 |
| 1812421 | topiramate 25 MG Sprinkle 24HR Extended Release Oral Capsule | PSN | b5f8da43-6daf-413c-9dcd-363617973738 | 5 |
| 1812425 | topiramate 50 MG Sprinkle 24HR Extended Release Oral Capsule | PSN | b5f8da43-6daf-413c-9dcd-363617973738 | 5 |
| 1812427 | Sprinkle 24 HR topiramate 100 MG Extended Release Oral Capsule | SCD | b5f8da43-6daf-413c-9dcd-363617973738 | 5 |
| 1494769 | Sprinkle 24 HR topiramate 150 MG Extended Release Oral Capsule | SCD | b5f8da43-6daf-413c-9dcd-363617973738 | 5 |
| 1812419 | Sprinkle 24 HR topiramate 200 MG Extended Release Oral Capsule | SCD | b5f8da43-6daf-413c-9dcd-363617973738 | 5 |
| 1812421 | Sprinkle 24 HR topiramate 25 MG Extended Release Oral Capsule | SCD | b5f8da43-6daf-413c-9dcd-363617973738 | 5 |
| 1812425 | Sprinkle 24 HR topiramate 50 MG Extended Release Oral Capsule | SCD | b5f8da43-6daf-413c-9dcd-363617973738 | 5 |
| 1812427 | topiramate 100 MG Sprinkle 24 HR Extended Release Oral Capsule | SY | b5f8da43-6daf-413c-9dcd-363617973738 | 5 |
| 1494769 | topiramate 150 MG Sprinkle 24 HR Extended Release Oral Capsule | SY | b5f8da43-6daf-413c-9dcd-363617973738 | 5 |
| 1812419 | topiramate 200 MG Sprinkle 24 HR Extended Release Oral Capsule | SY | b5f8da43-6daf-413c-9dcd-363617973738 | 5 |
| 1812421 | topiramate 25 MG Sprinkle 24HR Extended Release Oral Capsule | SY | b5f8da43-6daf-413c-9dcd-363617973738 | 5 |
| 1812425 | topiramate 50 MG Sprinkle 24HR Extended Release Oral Capsule | SY | b5f8da43-6daf-413c-9dcd-363617973738 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 72603-120-01 | 72603012001 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72603-120-01) | 2023-01-01 | 0000-00-00 | No | No | Current |